A Perth-based biotech, Rockeby Biomed, said on Tuesday it had stitched up a deal with Pacific Biotech in Thailand, giving it exclusive rights to two bird flu tests in the Asia-Pacific, Europe and South Africa. The first test, which takes 10 minutes, will be used on bird faeces and blood to detect the bird flu strain, avian influenza virus antigen, HSN1. A second rapid-screening test will be used on people to detect the deadly H5N1 strain, which is known to have killed 63 people in four Asian countries since first discovered in the region two years ago and has led to the culling of 150 million birds worldwide
Australian Financial Review -
BioBOOM Op/Ed: With all the money flowing in after H5N1 we expect more and more press releases relating to new tests or claimed technical breakouts from companies in the sector due to the bird flu threat. Gee thier stock went up too...go figure
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- ► 2006 (77)
- Glaxo & Institut Pasteur hope to adapt measles sho...
- Merck to Cut Jobs, Close or Sell 5 Plants
- C.D.C. Proposes New Rules in Effort to Prevent Dis...
- Harvard affiliated hospitals to share large detail...
- Doctors Objecting to Planned Cut in Medicare Fees
- Pope Addresses Genome Conference
- Mixed Results for Lipitor Vs. Zocor
- Genetic Find Stirs Debate on Race-Based Medicine
- Appetite-Suppressing Hormone Discovered
- Biotech groups push for small-business rule change...
- Australian company to launch bird flu tests for H5...
- Changing vaccine systems no easy shot - baltimores...
- Commission recommends patient ID standard
- ▼ November (13)